Global BCI and EEG Market Growth (Status and Outlook) 2023-2029
This report covers market analysis of BCI and EGG. A brain–computer interface (BCI), sometimes called a neural-control interface (NCI), mind-machine interface (MMI), direct neural interface (DNI), or brain–machine interface (BMI), is a direct communication pathway between an enhanced or wired brain and an external device.
An EEG, or electroencephalogram, is a test that records the electrical signals of the brain. Doctors use it to help diagnose epilepsy and sleep disorders.
LPI (LP Information)' newest research report, the “BCI and EEG Industry Forecast” looks at past sales and reviews total world BCI and EEG sales in 2022, providing a comprehensive analysis by region and market sector of projected BCI and EEG sales for 2023 through 2029. With BCI and EEG sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world BCI and EEG industry.
This Insight Report provides a comprehensive analysis of the global BCI and EEG landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on BCI and EEG portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global BCI and EEG market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for BCI and EEG and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global BCI and EEG.
The global BCI and EEG market size is projected to grow from US$ 689.7 million in 2022 to US$ 1367.2 million in 2029; it is expected to grow at a CAGR of 10.3% from 2023 to 2029.
Global BCI and EEG main manufactuers include Medtronic, Natus Medical, Nihon Kohden, NeuroPace Inc and Mindmaze SA, totally accounting for about 45% of the market. North America is the largest market of BCI and EEG, holding a share about 40%. As for the application of products, it is widely used in medical and consumer field. The most common application is in medical field, with a share about 80%. As for the types of products, it can be divided into Hardware and Software and Service. The most common type is Hardware, with a share over 77%.
This report presents a comprehensive overview, market shares, and growth opportunities of BCI and EEG market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Hardware
Software and Service
Segmentation by application
Medical
Consumer
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Medtronic
Natus Medical
Nihon Kohden
NeuroPace Inc
Mindmaze SA
G.TEC
BrainCo
InteraXon
Brain Products GmbH
EGI
Blackrock Microsystems LLC
Emotiv Inc
Micromed
ANT Neuro B.V
Compumedics Limited
NeuroSky, Inc.
Artinis Medical Systems BV
Cadwell
Advanced Brain Monitoring
NCC Medical
SYMTOP
Neuroelectrics
Please note: The report will take approximately 2 business days to prepare and deliver.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook